Navigation Links
Tumor Blood Flow can Improve Chemotherapy

A treatment for neuroblastoma that lands a one-two punch works best when the second punch is timed to take maximum advantage of the first one, according to results of studies at St. Jude Childrens Research Hospital. Neuroblastoma is a pediatric solid tumor that arises from cells in the peripheral nervous system.

The finding holds promise for improving neuroblastoma treatment by using the drug bevacizumab to block VEGF, a protein that stimulates blood vessel growth in tumors and then following with the chemotherapy drug topotecan, which depends on blood vessels to penetrate the tumor and kill the cancer cells. A report on this work appears in the current issue of Clinical Cancer Research.

Results of the current study are especially important because drugs such as bevacizumab are being evaluated in clinical trials for children with neuroblastoma. However, there are no standard guidelines for how much of the drug to give or when to give it.

Such guidelines would be especially helpful for developing combination therapy with both bevacizumab and chemotherapy drugs, not only for neuroblastoma, but also for other tumors.

The results of our study are a significant step toward establishing such guidelines, said Andrew Davidoff, M.D., director of surgical research at St. Jude, and the reports senior author.

The St. Jude team based their strategy on previous findings that suggested blocking VEGF at first improves the tumors vasculature, or blood vessel system, by eliminating weak and faulty vessels, while temporarily sparing healthy, normal blood vessels.

The investigators reasoned that if they treated tumors with bevacizumab first, the temporarily improved tumor circulation would more efficiently deliver topotecanbut only if they timed this one-two punch correctly.

A growing tumor releases VEGF to stimulate growth of the blood vessels that support its own growth, Davido
'"/>




Page: 1 2 3

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Radiofrequency Energy Cooks Tumors Without Surgery
3. New Liver Tumor Treatment
4. Latest Tumor Classification More Informative
5. New Technique For Benign Breast Tumors
6. Another Treatment Option for Benign Tumors
7. Understanding The Origin Of Tumors
8. Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors
9. Stem Cells, Tumor Cells Share Similar Properties: Scope For Treatment and Prevention?
10. Lipoma Arborescens: A Rare Tumor Of The Knee
11. Researchers Develop Mouse Model Of Brain Tumor

Post Your Comments:
(Date:12/2/2009)... , American Red Cross also part of the ...,, WASHINGTON, Dec. 2 /PRNewswire-USNewswire/ -...ibuted more than $1 million this year to help fund...o: http://www.newscom.com/cgi-bin/prnh/20090108/R...0,000, was given to help Philippine communities af...
(Date:12/2/2009)... , NASHVILLE, Tenn., Dec. 2 Aeg...usiness development company, has appointed Pearson... of Aegis, executive management team, Talbert will...rketing staff as they focus on solutions to help h...ps and physician relationships. ,, To this newl...
(Date:12/2/2009)... , BELLEVUE, Wash., Dec. 2 /PRNewswire-..., a leading online retailer of health, beauty, vis... now shipping to customers in China, India, and Br... than 3.5 billion international customers can shop...products on http://international.drugstore.com w...
(Date:12/2/2009)...study suggests the gene could be linked to life sp...hDay News) -- Sperm genes may affect life span in ...y females tend to live longer than males, Japanese...ice created using two female genomes -- bi-materna... mice created from the normal combination of a mal...
(Date:12/2/2009)... taking it for macular degeneration is not advise...althDay News) -- Women who take low-dose aspirin t...as well. , A new study by Harvard University re...nefit for aspirin in preventing age-related macula... sharp, central vision. , "The data indicate th...
Breaking Medicine News(10 mins):Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 3Health News:Aegis Health Group Hires Pearson Talbert as Chief Development Officer 2Health News:drugstore.com Continues Global Sales Expansion to More Than 3.5 Billion International Consumers 2Health News:Sperm Gene May Cause Men's Longevity Disadvantage 2Health News:In Women, Aspirin Might Ward Off Eye Trouble 2
...Society of Hypertension, Inc. (ASH) today announce...pertension and related cardiovascular disease -- t...hance the level of education of allied health prof... intended target groups, it is designed to improve...
...were the first in the area to benefit , , PALO AL...70s, have become the first people in Allentown, Pe... form of radiotherapy for cancer. A 72-year-old ma...ospital used RapidArc(TM) radiotherapy and image-g...
...fast, Inc. (NYSE: MED ) announced today that it ...ial results for the period ended March 31, 2009 on... the market. The Company will hold a conference ca...-0782 or (201) 689-8567, or can listen via a live ...
...swire-Asia-FirstCall/ -- Genesis,Pharmaceuticals E...sis" or the,"Company"), a U.S. pharmaceutical comp...Republic of China, today announced that it began m...i Ke Ke Li (an,antipyretic and antitussive granule...
...s little evidence for transfusions improving healt...view and analysis of the medical literature by a p...ference on Transfusion and Outcomes (ICCTO) he...ng given to patients. The vast majority of studie...
... Corporation (Nasdaq: KNSY ), a leading medical ...ons and technologies for a wide range of medical p...d quarter and first nine months of fiscal year 200...DA of $9.2 million. , Operating margin of 37...
Other Medicine News:Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 2Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 3Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 4Health News:RapidArc Radiotherapy Technology Enabling Fast, Accurate Treatments for Pennsylvania Cancer Patients 2Health News:RapidArc Radiotherapy Technology Enabling Fast, Accurate Treatments for Pennsylvania Cancer Patients 3Health News:Medifast, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Wednesday, April 29, 2009 2Health News:Genesis Pharmaceuticals Announces the Launch of Three TCM Products 2Health News:Genesis Pharmaceuticals Announces the Launch of Three TCM Products 3Health News:Blood Transfusion and Outcomes 2Health News:Blood Transfusion and Outcomes 3Health News:Blood Transfusion and Outcomes 4Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 2Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 3Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 4Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 5Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 6Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 7Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 8Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 9Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 10Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 11Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 12Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 13Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 14Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 15
(Date:12/2/2009)...WALTHAM, Mass. and NEW YORK, Dec. 2 /PRNewswire-Fi... ILI ) and NYU Langone Medical Center announced f...th Duke University on the genetics of osteoarthrit...rst" version of the Annals of Rheumatic Diseases a...f/ard.2009.113043v1.pdf . Results from the stu...
(Date:12/2/2009)...CKVILLE, Md., Dec. 2 Nov...le initial results from the first stage of a two-s...and immunogenicity of the company,s 2009 H1N1 viru... Novavax is conducting this study in collaboration...istration of the vaccine in Mexico and potentially...
(Date:12/2/2009)...RMINGHAM, Ala., Dec. 2 Adults ar...ed with cancer. For adults 65 and over, the odds o... of a man developing prostate cancer are one in si... one in nine. Vision loss threatens the overall h...juries, depression and inability to complete daily...
Breaking Medicine Technology:Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2Cell Phone May Reduce Bone Density in Hips 60122 1Cell Phone May Reduce Bone Density in Hips 60122 2Burner Balm Lip Balm Hits Home Run With L A Dodger Andre Ethier 60118 1Burner Balm Lip Balm Hits Home Run With L A Dodger Andre Ethier 60118 2Celebrate the Holidays with Drenchers 28R 29 60114 1Celebrate the Holidays with Drenchers 28R 29 60114 2
...ing as Arno Therapeutics, Inc. becomes a ...D, N.J., June 4 Arno Therapeutics,Inc., a biophar... for the,treatment of cancer, announced the succes...tional, Inc., a publicly traded company currently ...l continue to trade under the,symbol LRRI.OB until...
...eca (NYSE:,AZN) today announced that it submitted ...U.S. Food and Drug Administration (FDA) for approv...e/formoterol fumarate dihydrate),Inhalation Aeroso...a in,pediatric patients ages 6 to 11 years old. SY...intenance treatment of asthma in patients 12 years...
Other Medicine Technology:Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc. 2Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc. 3Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc. 4Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc. 5AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 2AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 3AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 4AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 5AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 6
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: